GAIL ECKHARDT to Antibodies, Monoclonal
This is a "connection" page, showing publications GAIL ECKHARDT has written about Antibodies, Monoclonal.
Connection Strength
0.119
-
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. Ann Oncol. 2018 07 01; 29(7):1561-1568.
Score: 0.092
-
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer. Int J Cancer. 2016 Jan 01; 138(1):195-205.
Score: 0.019
-
Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity. Ann Oncol. 2004 Dec; 15(12):1825-33.
Score: 0.009